| Literature DB >> 23651214 |
Congcong Wang1, Chunzhou Han, Tao Li, Dehao Yang, Xiaojiong Shen, Yinxin Fan, Yang Xu, Wenli Zheng, Chenzhong Fei, Lifang Zhang, Feiqun Xue.
Abstract
In mammalian cells, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) has recently been shown to be implicated in numerous apoptotic paradigms, especially in neuronal apoptosis, and has been demonstrated to play a vital role in some neurodegenerative disorders. However, this phenomenon has not been reported in protists. In the present study, we report for the first time that such a mechanism is involved in diclazuril-induced apoptosis in Eimeria tenella (E. tenella). We found that upon treatment of parasites with diclazuril, the expression levels of GAPDH transcript and protein were significantly increased in second-generation merozoites. Then, we examined the subcellular localization of GAPDH by fluorescence microscopy and Western blot analysis. The results show that a considerable amount of GAPDH protein appeared in the nucleus within diclazuril-treated second-generation merozoites; in contrast, the control group had very low levels of GAPDH in the nucleus. The glycolytic activity of GAPDH was kinetically analyzed in different subcellular fractions. A substantial decrease (48.5%) in glycolytic activity of GAPDH in the nucleus was displayed. Moreover, the activities of caspases-3, -9, and -8 were measured in cell extracts using specific caspase substrates. The data show significant increases in caspase-3 and caspase-9 activities in the diclazuril-treated group.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23651214 PMCID: PMC3655105 DOI: 10.1186/1297-9716-44-29
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Figure 1The overexpression of GAPDH in apoptotic second-generation merozoites induced by diclazuril. A. Representative Western blots showing the protein level of GAPDH. Tubulin serves as a loading control. B. The relative quantification of GAPDH protein level. The results were expressed as the mean ± SD of 3 experiments. *P < 0.05 vs. control group. C. Quantitative real-time PCR results showing the relative mRNA level of GAPDH. The results were expressed as the mean ± SD of 3 experiments performed in triplicate.*P < 0.05 vs. control group.
Figure 2Nuclear translocation and accumulation of endogenous GAPDH after diclazuril treatment. A difference in subcellular localization of endogenous GAPDH was observed in second-generation merozoites between the control group and the Treatment group. The distribution of endogenous GAPDH was detected by fluorescence microscopy; the GAPDH immunostaining was almost undetectable in the nuclei of second-generation merozoites of the control group (A). In contrast, the considerable GAPDH immunostaining (green) appeared to be in the nuclei of second-generation merozoites of the treatment group (B). DAPI staining (blue) to detect parasite nuclei. Merge is GAPDH immunostaining/DAPI staining overlay. Arrows show nuclei localization.
Figure 3The glycolytic activity of GAPDH in nuclear and cytoplasmic subfractions. A. The glycolytic activity of GAPDH was quantified by measuring the production of NADH at 340 nm for 5 min (μM NADH/mg protein). B. The relative GAPDH glycolytic activity. The results are expressed as the mean ± SD of 3 experiments performed in triplicate. **P < 0.01 vs. control group.
Figure 4Larger increases in caspase-3 and caspase-9 activity in apoptotic merozoites in the treatment group. The activities of caspase proteins in merozoites in the control group and the treatment group were measured using specific caspase kits. *P < 0.05 vs. control group.